New Concepts and Technologies in Reconstructive Hand Surgery

Clinics in Plastic Surgery

Volumn 39, Issue 4, 2012, Pages 445-451

  Schmitt, Taliah ^a   Talley, John ^a   Chang, James ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Hand trauma; Microvascular anastomosis; Nerve repair; Tissue engineering

Indexed keywords

BOTULINUM TOXIN A; CALCIUM PHOSPHATE; HYDROXYAPATITE;

BLOOD VESSEL SHUNT; BONE GRAFT; END TO END ANASTOMOSIS; END TO SIDE ANASTOMOSIS; FINGER REPLANTATION; FOREIGN BODY REACTION; FRACTURE FIXATION; FRACTURE NONUNION; HAND INJURY; HAND RECONSTRUCTION; HAND SURGERY; HUMAN; NERVE REGENERATION; PERIPHERAL NERVE INJURY; PLASTIC SURGEON; POSTOPERATIVE INFECTION; RAYNAUD PHENOMENON; REVIEW; SCAR FORMATION; SURGICAL TECHNIQUE; TENDON GRAFT; TISSUE ENGINEERING; TISSUE REGENERATION; TISSUE REPAIR; WOUND CLOSURE;

ADHESIVES; ANASTOMOSIS, SURGICAL; BONE TRANSPLANTATION; BOTULINUM TOXINS, TYPE A; CICATRIX; CYANOACRYLATES; GUIDED TISSUE REGENERATION; HAND BONES; HAND INJURIES; HUMANS; NEUROMUSCULAR AGENTS; NEUROSURGICAL PROCEDURES; OSTEOMYELITIS; PERIPHERAL NERVE INJURIES; POLOXAMER; RAYNAUD DISEASE; RECONSTRUCTIVE SURGICAL PROCEDURES; TENDONS; TISSUE ENGINEERING;

EID: 84867127569     PISSN: 00941298     EISSN: 15580504     Source Type: Journal    
DOI: 10.1016/j.cps.2012.07.013     Document Type: Review

References (50)

1. Bunnell S. Bunnell's surgery of the hand 1970, J. B. Lippincott Company, Philadelphia, PA, U.S.A.
2. Masquelet A.C., Begue T. The concept of induced membrane for reconstruction of long bone defects. Orthop Clin North Am 2010, 41(1):27-37. table of contents.
3. Flamans B., Pauchot J., Petite H., et al. Chir Main 2010, 29(5):307-314. [in French].
4. Powerski M., Maier B., Frank J., et al. Treatment of severe osteitis after elastic intramedullary nailing of a radial bone shaft fracture by using cancellous bone graft in Masquelet technique in a 13-year-old adolescent girl. J Pediatr Surg 2009, 44(8):e17-e19.
5. Apard T., Bigorre N., Cronier P., et al. Two-stage reconstruction of post-traumatic segmental tibia bone loss with nailing. Orthop Traumatol Surg Res 2010, 96(5):549-553.
6. Largey A., Faline A., Hebrard W., et al. Management of massive traumatic compound defects of the foot. Orthop Traumatol Surg Res 2009, 95(4):301-304.
7. Gouron R., Deroussen F., Juvet M., et al. Early resection of congenital pseudarthrosis of the tibia and successful reconstruction using the Masquelet technique. J Bone Joint Surg Br 2011, 93(4):552-554.
8. Seiler J.G., Chu C.R., Amiel D., et al. The Marshall R. Urist Young Investigator Award. Autogenous flexor tendon grafts. Biologic mechanisms for incorporation. Clin Orthop Relat Res 1997, (345):239-247.
9. Longo U.G., Lamberti A., Petrillo S., et al. Scaffolds in tendon tissue engineering. Stem Cells Int 2012, 2012:1-12.
10. Pridgen B.C., Woon C.Y., Kim M., et al. Flexor tendon tissue engineering: acellularization of human flexor tendons with preservation of biomechanical properties and biocompatibility. Tissue Eng Part C Methods 2011, 17(8):819-828.
11. Caliari S.R., Ramirez M.A., Harley B.A. The development of collagen-GAG scaffold-membrane composites for tendon tissue engineering. Biomaterials 2011, 32(34):8990-8998.
12. Murphy K.D., Mushkudiani I.A., Kao D., et al. Successful incorporation of tissue-engineered porcine small-intestinal submucosa as substitute flexor tendon graft is mediated by elevated TGF-beta1 expression in the rabbit. J Hand Surg Am 2008, 33(7):1168-1178.
13. Abousleiman R.I., Reyes Y., McFetridge P., et al. Tendon tissue engineering using cell-seeded umbilical veins cultured in a mechanical stimulator. Tissue Eng Part A 2009, 15(4):787-795.
14. Vaquette C., Slimani S., Kahn C.J.F., et al. A poly(lactic-co-glycolic acid) knitted scaffold for tendon tissue engineering: an in vitro and in vivo study. J Biomater Sci Polym Ed 2010, 21(13):1737-1760.
15. Zhang A.Y., Bates S.J., Morrow E., et al. Tissue-engineered intrasynovial tendons: optimization of acellularization and seeding. J Rehabil Res Dev 2009, 46(4):489-498.
16. Chong A.K., Riboh J., Smith R.L., et al. Flexor tendon tissue engineering: acellularized and reseeded tendon constructs. Plast Reconstr Surg 2009, 123(6):1759-1766.
17. Angelidis I.K., Thorfinn J., Connolly I.D., et al. Tissue engineering of flexor tendons: the effect of a tissue bioreactor on adipoderived stem cell-seeded and fibroblast-seeded tendon constructs. J Hand Surg Am 2010, 35(9):1466-1472.
18. Omae H., Zhao C., Sun Y.L., et al. Multilayer tendon slices seeded with bone marrow stromal cells: a novel composite for tendon engineering. J Orthop Res 2009, 27(7):937-942.
19. Yokoya S., Mochizuki Y., Natsu K., et al. Rotator cuff regeneration using a bioabsorbable material with bone marrow-derived mesenchymal stem cells in a rabbit model. Am J Sports Med 2012 Jun, 40(6):1259-1268.
20. Kryger G.S., Chong A.K., Costa M., et al. A comparison of tenocytes and mesenchymal stem cells for use in flexor tendon tissue engineering. J Hand Surg Am 2007, 32(5):597-605.
21. Costa M.A., Wu C., Pham B.V., et al. Tissue engineering of flexor tendons: optimization of tenocyte proliferation using growth factor supplementation. Tissue Eng 2006, 12(7):1937-1943.
22. Raghavan S.S., Woon C.Y., Kraus A., et al. Optimization of human tendon tissue engineering: synergistic effects of growth factors for use in tendon scaffold repopulation. Plast Reconstr Surg 2012, 129(2):479-489.
23. Woon C.Y., Kraus A., Raghavan S.S., et al. Three-dimensional-construct bioreactor conditioning in human tendon tissue engineering. Tissue Eng Part A 2011, 17(19-20):2561-2572.
24. Riboh J., Chong A.K., Pham H., et al. Optimization of flexor tendon tissue engineering with a cyclic strain bioreactor. J Hand Surg Am 2008, 33(8):1388-1396.
25. Chimutengwende Gordon M., Khan W. Recent advances and developments in neural repair and regeneration for hand surgery. Open Orthop J 2012, 6:103-107.
26. Moy O.J., Peimer C.A., Koniuch M.P., et al. Fibrin seal adhesive, versus nonabsorable microsuture in peripheral nerve repair. J Hand Surg Am 1988, 13(2):273-278.
27. Lauto A., Foster L.J., Avolio A., et al. Sutureless nerve repair with laser-activated chitosan adhesive: a pilot in vivo study. Photomed Laser Surg 2008, 26(3):227-234.
28. Fernandez E., Lauretti L., Tufo T., et al. End-to-side nerve neurorrhaphy: critical appraisal of experimental and clinical data. Acta Neurochir Suppl 2007, 100:77-84.
29. Deal D.N., Griffin J.W., Hogan M.V. Nerve conduits for nerve repair or reconstruction. J Am Acad Orthop Surg 2012, 20(2):63-68.
30. Brooks D.N., Weber R.V., Chao J.D., et al. Processed nerve allografts for peripheral nerve reconstruction: a multicenter study of utilization and outcomes in sensory, mixed, and motor nerve reconstructions, processed nerve allografts for peripheral nerve reconstruction: a multicenter study of utilization and outcomes in sensory, mixed, and motor nerve reconstructions. Microsurgery 2012, 32(1):1-14.
31. Wang Y., Zhao Z., Ren Z., et al. Recellularized nerve allografts with differentiated mesenchymal stem cells promote peripheral nerve regeneration. Neurosci Lett 2012, 514(1):96-101.
32. Liu W., Ren Y., Bossert A., et al. Allotransplanted neurons used to repair peripheral nerve injury do not elicit overt immunogenicity. PLoS One 2012, 7(2):e31675.
33. Pratt G.F., Rozen W.M., Westwood A., et al. Technology-assisted and sutureless microvascular anastomoses: evidence for current techniques. Microsurgery 2012, 32(1):68-76.
34. Chang E.I., Galvez M.G., Glotzbach J.P., et al. Vascular anastomosis using controlled phase transitions in poloxamer gels. Nat Med 2011, 17(9):1147-1152.
35. Fregene A., Ditmars D., Siddiqui A. Botulinum toxin type A: a treatment option for digital ischemia in patients with Raynaud's phenomenon. J Hand Surg Am 2009, 34(3):446-452.
36. Mannava S., Plate J.F., Stone A.V., et al. Recent advances for the management of Raynaud phenomenon using botulinum neurotoxin A. J Hand Surg Am 2011, 36(10):1708-1710.
37. Neumeister M.W. Botulinum toxin type A in the treatment of Raynaud's phenomenon. J Hand Surg Am 2010, 35(12):2085-2092.
38. Sycha T., Graninger M., Auff E., et al. Botulinum toxin in the treatment of Raynaud's phenomenon: a pilot study. Eur J Clin Invest 2004, 34(4):312-313.
39. Neumeister M.W., Chambers C.B., Herron M.S., et al. Botox therapy for ischemic digits. Plast Reconstr Surg 2009, 124(1):191-201.
40. Van Beek A.L., Lim P.K., Gear A.J., et al. Management of vasospastic disorders with botulinum toxin A. Plast Reconstr Surg 2007, 119(1):217-226.
41. Iorio M.L., Masden D.L., Higgins J.P. Botulinum toxin A treatment of Raynaud's phenomenon: a review. Semin Arthritis Rheum 2012, 41(4):599-603.
42. Tollefson T.T., Kamangar F., Aminpour S., et al. Comparison of effectiveness of silicone gel sheeting with microporous paper tape in the prevention of hypertrophic scarring in a rabbit model. Arch Facial Plast Surg 2011, 14(1):45-51.
43. Tziotzios C., Profyris C., Sterling J. Cutaneous scarring: pathophysiology, molecular mechanisms, and scar reduction therapeutics: part II. Strategies to reduce scar formation after dermatologic procedures. J Am Acad Dermatol 2012, 66(1):13-24.
44. Morganroth P., Wilmot A.C., Miller C. Over-the-counter scar products for postsurgical patients: disparities between online advertised benefits and evidence regarding efficacy. J Am Acad Dermatol 2009, 61(6):e31-e47.
45. Gurtner G.C., Dauskardt R.H., Wong V.W., et al. Improving cutaneous scar formation by controlling the mechanical environment: large animal and phase I studies. Ann Surg 2011, 254(2):217-225.
46. Shores J.T., Imbriglia J.E., Lee W.P. The current state of hand transplantation. J Hand Surg Am 2011, 36(11):1862-1867.
47. O'Doherty J.E., Lebedev M.A., Ifft P.J., et al. Active tactile exploration using a brain-machine-brain interface. Nature 2011, 479(7372):228-231.
48. Rinkevich Y., Lindau P., Ueno H., et al. Germ-layer and lineage-restricted stem/progenitors regenerate the mouse digit tip. Nature 2011, 476(7361):409-413.
49. Proubasta I.R., Itarte J.P., Lamas C.G., et al. The spacer block technique in osteomyelitis of the phalangeal bones of the hand. Acta Orthop Belg 2004, 70(2):162-165.
50. Smith L., Polsky D., Franks A.G. Botulinum toxin-A for the treatment of Raynaud syndrome. Arch Dermatol 2012, 148(4):426-428.